Overview

Ibuprofen/Caffeine Lower Back or Neck Pain Study

Status:
Completed

Trial end date:
2017-09-28

Target enrollment:

Participant gender:

Summary

To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.

Phase:

Phase 3

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Caffeine
Ibuprofen